Quick answer
Stem cell therapy for diabetes focuses on improving glucose control and HbA1C levels while restoring damaged tissues from complications such as chronic foot ulcers. This approach aims to reduce the risk of amputation and enhance the patient's overall quality of life.
Key takeaways
- Assists in controlling blood glucose levels and reducing HbA1C in diabetic patients.
- Restores tissues damaged by diabetic foot ulcers to avoid potential amputation.
- Utilizes highly safe Autologous Adipose-derived Stem Cell (ADSC) cultivation technology.
- Manufacturing process under GMP Class 100 standards, supporting 6,000 lots per year.
Advancements in Stem Cell Therapy for Diabetes
Diabetes is a condition characterized by persistently high blood sugar levels, impacting various bodily systems. Studies conducted by EHL BIO indicate that stem cell therapy positively influences glucose control and HbA1C levels, which are critical indicators for assessing disease severity.
The core of regenerative medicine for diabetic patients lies in the stem cells' ability to differentiate into specialized tissues, repairing areas damaged by chronic hyperglycemia. This innovation represents a significant step in enhancing disease management efficacy, aiming for longevity paired with a high quality of life (Aging Well).
Managing Diabetic Foot and Chronic Wound Healing
One of the most severe complications of diabetes is chronic foot ulcers, or Diabetic Foot, which carries a high risk of infection and amputation. EHL BIO utilizes stem cells as a therapeutic option to restore damaged tissues and stimulate wound healing.
Observations have shown that following prescribed stem cell protocols, chronic wound tissues exhibit significantly improved healing. The stem cells stimulate new blood vessel formation and repair localized skin cells, helping patients preserve their limbs and return to a more normal lifestyle, which remains the ultimate goal of our medical and research teams.
Our goal is to utilize stem cell technology to enhance quality of life and provide new hope in precisely managing diabetes.
Safety Standards and South Korean Technology
EHL BIO prioritizes patient safety above all. We utilize Autologous Adipose-derived Stem Cells (ADSCs), which minimizes the risk of immune rejection. The entire process is conducted within our GMP (Good Manufacturing Practices) facilities, certified by relevant authorities in South Korea.
We employ Class 100 Clean Room technology and cell storage systems at -196°C to maintain optimal cell quality and viability. With a capacity to process 6,000 lots annually, we ensure patients receive high-purity cells for restoration according to the plans evaluated by the EHL team.
Service Procedures for Patients from Thailand
For patients in Thailand, EHL Thailand provides a dedicated Thai-speaking coordination team to facilitate every step. It begins with submitting an online consultation for medical document evaluation by our Korean doctors. The team then assists in travel planning and scheduling health examinations at the EHL Cell Clinic in Seoul.
Following the physical assessment, fat samples are collected for cultivation in standard laboratories. Once cell quality is verified, the patient receives services according to the plan, with close follow-up monitored even after their return to Thailand to ensure the process meets restoration and quality of life goals.
Frequently asked questions
How do stem cells help manage diabetic wounds?
Stem cells possess the Homing Effect, allowing them to travel to injured sites to stimulate new blood vessel formation and repair damaged skin tissue, supporting better wound healing trends.
How safe is it to use autologous cells?
It is safe according to the EHL team's evaluation as the cells are extracted from the patient's own fat tissue, reducing the risk of immune rejection and side effects associated with foreign substances.
What are the goals of restoration with stem cells?
The goal is to restore degenerated tissues, assist in more effective blood sugar control, and enhance the patient's long-term quality of life.
Related conditions
Based on EHL BIO information: EHL BIO · EHL BIO · EHL BIO · EHL BIO. Each care plan follows an individual EHL assessment.
